Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

[Drug-drug interactions you should know!]

Voigt N, Ort K, Sossalla S.

Fortschr Neurol Psychiatr. 2019 May;87(5):320-332. doi: 10.1055/a-0894-9924. Epub 2019 May 24. German.

PMID:
31125990
2.

[Drug-drug Interactions You Should Know!]

Voigt N, Ort K, Sossalla S.

Pneumologie. 2019 May;73(5):306-318. doi: 10.1055/a-0863-6242. Epub 2019 May 13. German.

PMID:
31083751
3.

Transcranial motor-evoked potentials for prediction of postoperative neurologic and motor deficit following surgery for thoracolumbar scoliosis.

Miller SM, Donegan SW, Voigt N, Eltorai AEM, Nguyen J, Machan JT, Daniels AH, Shetty T.

Orthop Rev (Pavia). 2019 Mar 12;11(1):7757. doi: 10.4081/or.2019.7757. eCollection 2019 Feb 26.

4.

N-glycosylation-dependent regulation of hK2P17.1 currents.

Wiedmann F, Schlund D, Voigt N, Ratte A, Kraft M, Katus HA, Schmidt C.

Mol Biol Cell. 2019 Jun 1;30(12):1425-1436. doi: 10.1091/mbc.E18-10-0687. Epub 2019 Apr 10.

PMID:
30969900
5.

[Drug-drug interactions you should know!]

Voigt N, Ort K, Sossalla S.

Dtsch Med Wochenschr. 2019 Feb;144(4):264-275. doi: 10.1055/a-0160-8413. Epub 2019 Jan 31. German.

PMID:
30703807
6.

Ryanodine receptor dysfunction and the resolution revolution: how Nobel Prize-winning techniques transform cardiovascular research.

Voigt N, Lehnart SE.

Cardiovasc Res. 2018 Dec 1;114(14):e106-e109. doi: 10.1093/cvr/cvy235. No abstract available.

PMID:
30476015
7.

ESC Congress 2018 highlights in basic science: a report from the Scientists of Tomorrow.

Schmidt C, Voigt N.

Cardiovasc Res. 2018 Nov 1;114(13):e103-e105. doi: 10.1093/cvr/cvy234. No abstract available.

PMID:
30351376
8.

Axial Tubule Junctions Activate Atrial Ca2+ Release Across Species.

Brandenburg S, Pawlowitz J, Fakuade FE, Kownatzki-Danger D, Kohl T, Mitronova GY, Scardigli M, Neef J, Schmidt C, Wiedmann F, Pavone FS, Sacconi L, Kutschka I, Sossalla S, Moser T, Voigt N, Lehnart SE.

Front Physiol. 2018 Oct 8;9:1227. doi: 10.3389/fphys.2018.01227. eCollection 2018.

9.

German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management.

Thomas D, Christ T, Fabritz L, Goette A, Hammwöhner M, Heijman J, Kockskämper J, Linz D, Odening KE, Schweizer PA, Wakili R, Voigt N.

Clin Res Cardiol. 2019 Jun;108(6):577-599. doi: 10.1007/s00392-018-1377-1. Epub 2018 Oct 10. Review.

PMID:
30306295
10.

Major effects on blood-retina barrier passage by minor alterations in design of polybutylcyanoacrylate nanoparticles.

You Q, Hopf T, Hintz W, Rannabauer S, Voigt N, van Wachem B, Henrich-Noack P, Sabel BA.

J Drug Target. 2019 Mar;27(3):338-346. doi: 10.1080/1061186X.2018.1531416. Epub 2018 Nov 26.

PMID:
30280953
11.

Sarcoplasmic reticulum calcium leak contributes to arrhythmia but not to heart failure progression.

Mohamed BA, Hartmann N, Tirilomis P, Sekeres K, Li W, Neef S, Richter C, Zeisberg EM, Kattner L, Didié M, Guan K, Schmitto JD, Lehnart SE, Luther S, Voigt N, Seidler T, Sossalla S, Hasenfuss G, Toischer K.

Sci Transl Med. 2018 Sep 12;10(458). pii: eaan0724. doi: 10.1126/scitranslmed.aan0724. Erratum in: Sci Transl Med. 2019 Jan 9;11(474):.

PMID:
30209242
12.

Prof Niels Voigt talks to Prof Stanley Nattel about advances in atrial fibrillation research and career insights.

Voigt N, Nattel S.

Cardiovasc Res. 2018 Jul 1;114(8):e65. doi: 10.1093/cvr/cvy142. No abstract available.

PMID:
30052897
13.

Atrial fibrillation and heart failure-associated remodeling of two-pore-domain potassium (K2P) channels in murine disease models: focus on TASK-1.

Wiedmann F, Schulte JS, Gomes B, Zafeiriou MP, Ratte A, Rathjens F, Fehrmann E, Scholz B, Voigt N, Müller FU, Thomas D, Katus HA, Schmidt C.

Basic Res Cardiol. 2018 Jun 7;113(4):27. doi: 10.1007/s00395-018-0687-9.

PMID:
29881975
14.

Determination of optimal positive end-expiratory pressure based on respiratory compliance and electrical impedance tomography: a pilot clinical comparative trial.

Karsten J, Voigt N, Gillmann HJ, Stueber T.

Biomed Tech (Berl). 2019 Apr 24;64(2):135-145. doi: 10.1515/bmt-2017-0103.

PMID:
29874190
15.

Supervised Physical Activity and Improved Functional Capacity among Adults Living with HIV: A Systematic Review.

Voigt N, Cho H, Schnall R.

J Assoc Nurses AIDS Care. 2018 Sep - Oct;29(5):667-680. doi: 10.1016/j.jana.2018.05.001. Epub 2018 May 31.

PMID:
29861318
16.

Niels Voigt talks to W. Jonathan Lederer, keynote lecturer at the "Göttingen Channels" Symposium 2017.

Voigt N, Lederer WJ.

Cardiovasc Res. 2018 Feb 1;114(2):e14. doi: 10.1093/cvr/cvx241. No abstract available.

PMID:
29373724
17.

Report on the Ion Channel Symposium : Organized by the German Cardiac Society Working Group on Cellular Electrophysiology (AG 18).

Voigt N, Mason F, Thomas D.

Herzschrittmacherther Elektrophysiol. 2018 Mar;29(1):4-13. doi: 10.1007/s00399-017-0549-4. Epub 2018 Jan 8. Review.

PMID:
29313139
18.

Muscarinic type-1 receptors contribute to IK,ACh in human atrial cardiomyocytes and are upregulated in patients with chronic atrial fibrillation.

Heijman J, Kirchner D, Kunze F, Chrétien EM, Michel-Reher MB, Voigt N, Knaut M, Michel MC, Ravens U, Dobrev D.

Int J Cardiol. 2018 Mar 15;255:61-68. doi: 10.1016/j.ijcard.2017.12.050. Epub 2017 Dec 22.

19.

In search for novel functions of adenosine 5'-triphosphate (ATP) in the heart.

Meyer T, Voigt N.

Cardiovasc Res. 2017 Dec 1;113(14):e59-e60. doi: 10.1093/cvr/cvx207. No abstract available.

PMID:
29186438
20.

The inward rectifier current inhibitor PA-6 terminates atrial fibrillation and does not cause ventricular arrhythmias in goat and dog models.

Ji Y, Varkevisser R, Opacic D, Bossu A, Kuiper M, Beekman JDM, Yang S, Khan AP, Dobrev D, Voigt N, Wang MZ, Verheule S, Vos MA, van der Heyden MAG.

Br J Pharmacol. 2017 Aug;174(15):2576-2590. doi: 10.1111/bph.13869. Epub 2017 Jun 28.

21.

Stretch-activated two-pore-domain (K2P) potassium channels in the heart: Focus on atrial fibrillation and heart failure.

Schmidt C, Wiedmann F, Kallenberger SM, Ratte A, Schulte JS, Scholz B, Müller FU, Voigt N, Zafeiriou MP, Ehrlich JR, Tochtermann U, Veres G, Ruhparwar A, Karck M, Katus HA, Thomas D.

Prog Biophys Mol Biol. 2017 Nov;130(Pt B):233-243. doi: 10.1016/j.pbiomolbio.2017.05.004. Epub 2017 May 16.

PMID:
28526353
22.

Electrical brain stimulation induces dendritic stripping but improves survival of silent neurons after optic nerve damage.

Henrich-Noack P, Sergeeva EG, Eber T, You Q, Voigt N, Köhler J, Wagner S, Lazik S, Mawrin C, Xu G, Biswas S, Sabel BA, Leung CK.

Sci Rep. 2017 Apr 4;7(1):627. doi: 10.1038/s41598-017-00487-z.

23.

In-situ biogas upgrading with pulse H2 additions: The relevance of methanogen adaption and inorganic carbon level.

Agneessens LM, Ottosen LDM, Voigt NV, Nielsen JL, de Jonge N, Fischer CH, Kofoed MVW.

Bioresour Technol. 2017 Jun;233:256-263. doi: 10.1016/j.biortech.2017.02.016. Epub 2017 Feb 9.

PMID:
28285216
24.

Influence of intraoperative positive end-expiratory pressure level on pulmonary complications in emergency major trauma surgery.

Stueber T, Karsten J, Voigt N, Wilhelmi M.

Arch Med Sci. 2017 Mar 1;13(2):396-403. doi: 10.5114/aoms.2016.59868. Epub 2016 May 12.

25.

Multidrug resistance transporter-1 and breast cancer resistance protein protect against ovarian toxicity, and are essential in ovarian physiology.

Brayboy LM, Oulhen N, Long S, Voigt N, Raker C, Wessel GM.

Reprod Toxicol. 2017 Apr;69:121-131. doi: 10.1016/j.reprotox.2017.02.002. Epub 2017 Feb 12.

26.

Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy.

Schmidt C, Wiedmann F, Zhou XB, Heijman J, Voigt N, Ratte A, Lang S, Kallenberger SM, Campana C, Weymann A, De Simone R, Szabo G, Ruhparwar A, Kallenbach K, Karck M, Ehrlich JR, Baczkó I, Borggrefe M, Ravens U, Dobrev D, Katus HA, Thomas D.

Eur Heart J. 2017 Jun 7;38(22):1764-1774. doi: 10.1093/eurheartj/ehw559.

PMID:
28057773
27.

Nucleoside Diphosphate Kinase-C Suppresses cAMP Formation in Human Heart Failure.

Abu-Taha IH, Heijman J, Hippe HJ, Wolf NM, El-Armouche A, Nikolaev VO, Schäfer M, Würtz CM, Neef S, Voigt N, Baczkó I, Varró A, Müller M, Meder B, Katus HA, Spiger K, Vettel C, Lehmann LH, Backs J, Skolnik EY, Lutz S, Dobrev D, Wieland T.

Circulation. 2017 Feb 28;135(9):881-897. doi: 10.1161/CIRCULATIONAHA.116.022852. Epub 2016 Dec 7.

PMID:
27927712
28.

Finding Ms or Mr Right: Which miRNA to target in AF?

Molina CE, Voigt N.

J Mol Cell Cardiol. 2017 Jan;102:22-25. doi: 10.1016/j.yjmcc.2016.11.007. Epub 2016 Nov 17. Review. No abstract available.

PMID:
27866930
29.

Micro-scale H2-CO2 Dynamics in a Hydrogenotrophic Methanogenic Membrane Reactor.

Garcia-Robledo E, Ottosen LD, Voigt NV, Kofoed MW, Revsbech NP.

Front Microbiol. 2016 Aug 17;7:1276. doi: 10.3389/fmicb.2016.01276. eCollection 2016.

30.

Constraint-Induced Aphasia Therapy in the Acute Stage: What Is the Key Factor for Efficacy? A Randomized Controlled Study.

Woldag H, Voigt N, Bley M, Hummelsheim H.

Neurorehabil Neural Repair. 2017 Jan;31(1):72-80. Epub 2016 Aug 9.

PMID:
27506677
31.

Atrial-Selective Potassium Channel Blockers.

Voigt N, Dobrev D.

Card Electrophysiol Clin. 2016 Jun;8(2):411-21. doi: 10.1016/j.ccep.2016.02.005. Epub 2016 Mar 24. Review.

PMID:
27261831
32.

Dysfunction of the β2-spectrin-based pathway in human heart failure.

Smith SA, Hughes LD, Kline CF, Kempton AN, Dorn LE, Curran J, Makara M, Webb TR, Wright P, Voigt N, Binkley PF, Janssen PM, Kilic A, Carnes CA, Dobrev D, Rasband MN, Hund TJ, Mohler PJ.

Am J Physiol Heart Circ Physiol. 2016 Jun 1;310(11):H1583-91. doi: 10.1152/ajpheart.00875.2015. Epub 2016 Apr 22.

33.

The combined effects of ranolazine and dronedarone on human atrial and ventricular electrophysiology.

Hartmann N, Mason FE, Braun I, Pabel S, Voigt N, Schotola H, Fischer TH, Dobrev D, Danner BC, Renner A, Gummert J, Belardinelli L, Frey N, Maier LS, Hasenfuss G, Sossalla S.

J Mol Cell Cardiol. 2016 May;94:95-106. doi: 10.1016/j.yjmcc.2016.03.012. Epub 2016 Apr 4.

PMID:
27056421
34.

Response to Letter Regarding Article, "Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation".

Schmidt C, Wiedmann F, Voigt N, Zhou XB, Heijman J, Lang S, Albert V, Kallenberger S, Ruhparwar A, Szabó G, Kallenbach K, Karck M, Borggrefe M, Biliczki P, Ehrlich JR, Baczkó I, Lugenbiel P, Schweizer PA, Donner BC, Katus HA, Dobrev D, Thomas D.

Circulation. 2016 Mar 15;133(11):e440-1. doi: 10.1161/CIRCULATIONAHA.115.020662. No abstract available.

PMID:
26976923
35.

S-glutathiolation impairs phosphoregulation and function of cardiac myosin-binding protein C in human heart failure.

Stathopoulou K, Wittig I, Heidler J, Piasecki A, Richter F, Diering S, van der Velden J, Buck F, Donzelli S, Schröder E, Wijnker PJ, Voigt N, Dobrev D, Sadayappan S, Eschenhagen T, Carrier L, Eaton P, Cuello F.

FASEB J. 2016 May;30(5):1849-64. doi: 10.1096/fj.201500048. Epub 2016 Feb 2.

36.

Influence of different electrode belt positions on electrical impedance tomography imaging of regional ventilation: a prospective observational study.

Karsten J, Stueber T, Voigt N, Teschner E, Heinze H.

Crit Care. 2016 Jan 8;20:3. doi: 10.1186/s13054-015-1161-9.

37.

The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis.

Heijman J, Algalarrondo V, Voigt N, Melka J, Wehrens XH, Dobrev D, Nattel S.

Cardiovasc Res. 2016 Apr 1;109(4):467-79. doi: 10.1093/cvr/cvv275. Epub 2015 Dec 23. Review.

38.

New antiarrhythmic targets in atrial fibrillation.

Voigt N, Heijman J, Dobrev D.

Future Cardiol. 2015;11(6):645-54. doi: 10.2217/fca.15.67. Epub 2015 Nov 26. Review.

PMID:
26609872
39.

Computational models of atrial cellular electrophysiology and calcium handling, and their role in atrial fibrillation.

Heijman J, Erfanian Abdoust P, Voigt N, Nattel S, Dobrev D.

J Physiol. 2016 Feb 1;594(3):537-53. doi: 10.1113/JP271404. Epub 2015 Dec 28. Review.

40.

Methods for isolating atrial cells from large mammals and humans.

Voigt N, Pearman CM, Dobrev D, Dibb KM.

J Mol Cell Cardiol. 2015 Sep;86:187-98. doi: 10.1016/j.yjmcc.2015.07.006. Epub 2015 Jul 15. Review.

41.

Expression and function of Kv1.1 potassium channels in human atria from patients with atrial fibrillation.

Glasscock E, Voigt N, McCauley MD, Sun Q, Li N, Chiang DY, Zhou XB, Molina CE, Thomas D, Schmidt C, Skapura DG, Noebels JL, Dobrev D, Wehrens XH.

Basic Res Cardiol. 2015 Sep;110(5):505. doi: 10.1007/s00395-015-0505-6. Epub 2015 Jul 11.

42.

Repetitive Transcorneal Alternating Current Stimulation Reduces Brain Idling State After Long-term Vision Loss.

Sergeeva EG, Bola M, Wagner S, Lazik S, Voigt N, Mawrin C, Gorkin AG, Waleszczyk WJ, Sabel BA, Henrich-Noack P.

Brain Stimul. 2015 Nov-Dec;8(6):1065-73. doi: 10.1016/j.brs.2015.06.006. Epub 2015 Jun 18.

PMID:
26145756
43.

Atrial Fibrillation Activates AMP-Dependent Protein Kinase and its Regulation of Cellular Calcium Handling: Potential Role in Metabolic Adaptation and Prevention of Progression.

Harada M, Tadevosyan A, Qi X, Xiao J, Liu T, Voigt N, Karck M, Kamler M, Kodama I, Murohara T, Dobrev D, Nattel S.

J Am Coll Cardiol. 2015 Jul 7;66(1):47-58. doi: 10.1016/j.jacc.2015.04.056.

44.

Upregulation of K(2P)3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation.

Schmidt C, Wiedmann F, Voigt N, Zhou XB, Heijman J, Lang S, Albert V, Kallenberger S, Ruhparwar A, Szabó G, Kallenbach K, Karck M, Borggrefe M, Biliczki P, Ehrlich JR, Baczkó I, Lugenbiel P, Schweizer PA, Donner BC, Katus HA, Dobrev D, Thomas D.

Circulation. 2015 Jul 14;132(2):82-92. doi: 10.1161/CIRCULATIONAHA.114.012657. Epub 2015 May 7.

PMID:
25951834
45.

Calcium Handling Abnormalities as a Target for Atrial Fibrillation Therapeutics: How Close to Clinical Implementation?

Heijman J, Voigt N, Ghezelbash S, Schirmer I, Dobrev D.

J Cardiovasc Pharmacol. 2015 Dec;66(6):515-22. doi: 10.1097/FJC.0000000000000253. Review.

PMID:
25830486
46.

Identification of microRNA-mRNA dysregulations in paroxysmal atrial fibrillation.

Chiang DY, Zhang M, Voigt N, Alsina KM, Jakob H, Martin JF, Dobrev D, Wehrens XH, Li N.

Int J Cardiol. 2015 Apr 1;184:190-7. doi: 10.1016/j.ijcard.2015.01.075. Epub 2015 Jan 28.

47.

Dysfunction in the βII spectrin-dependent cytoskeleton underlies human arrhythmia.

Smith SA, Sturm AC, Curran J, Kline CF, Little SC, Bonilla IM, Long VP, Makara M, Polina I, Hughes LD, Webb TR, Wei Z, Wright P, Voigt N, Bhakta D, Spoonamore KG, Zhang C, Weiss R, Binkley PF, Janssen PM, Kilic A, Higgins RS, Sun M, Ma J, Dobrev D, Zhang M, Carnes CA, Vatta M, Rasband MN, Hund TJ, Mohler PJ.

Circulation. 2015 Feb 24;131(8):695-708. doi: 10.1161/CIRCULATIONAHA.114.013708. Epub 2015 Jan 28.

48.

Alterations in the interactome of serine/threonine protein phosphatase type-1 in atrial fibrillation patients.

Chiang DY, Lebesgue N, Beavers DL, Alsina KM, Damen JM, Voigt N, Dobrev D, Wehrens XH, Scholten A.

J Am Coll Cardiol. 2015 Jan 20;65(2):163-73. doi: 10.1016/j.jacc.2014.10.042.

49.

Application of the RIMARC algorithm to a large data set of action potentials and clinical parameters for risk prediction of atrial fibrillation.

Ravens U, Katircioglu-Öztürk D, Wettwer E, Christ T, Dobrev D, Voigt N, Poulet C, Loose S, Simon J, Stein A, Matschke K, Knaut M, Oto E, Oto A, Güvenir HA.

Med Biol Eng Comput. 2015 Mar;53(3):263-73. doi: 10.1007/s11517-014-1232-0. Epub 2014 Dec 3.

PMID:
25466224
50.

Loss of microRNA-106b-25 cluster promotes atrial fibrillation by enhancing ryanodine receptor type-2 expression and calcium release.

Chiang DY, Kongchan N, Beavers DL, Alsina KM, Voigt N, Neilson JR, Jakob H, Martin JF, Dobrev D, Wehrens XH, Li N.

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1214-22. doi: 10.1161/CIRCEP.114.001973. Epub 2014 Nov 11.

Supplemental Content

Support Center